Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.382ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.382ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.395ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.395ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.323ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.323ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FU.1.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FU.1.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FY.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FY.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FN.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-643.025Germany
FN.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
BQ.1.1.74ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BQ.1.1.74ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XBB.1.5.53ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
XBB.1.5.53ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.62ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.62ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.391ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.391ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.448ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.448ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
C.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
C.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
Q.1 (Alpha)ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
Q.1 (Alpha)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
AY.46 (Delta)ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
AY.46 (Delta)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.54ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.54ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.196ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.196ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.6ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.6ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.57ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.57ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.34ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.34ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
C.36.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
C.36.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.418ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.418ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.389ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.389ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.177.53ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.177.53ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.363ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.363ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HV.1.7ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HV.1.7ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used